NVDA
NVIDIA Corporation
NVDA has the edge over VRNS overall, supported by stronger valuation and stronger modeled upside.
VRNS
Varonis Systems, Inc.
VRNS's outlook is improving, though it still trails on the overall score.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
VRNS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Healthy | |
| Unavailable |
VRNS's revenue and cash flow are currently healthy, but its profitability is weak. There isn't enough data to rate its balance sheet.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
VRNS PE Valuation
VRNS has no meaningful PE right now: it lost money over the past year.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
VRNS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Low |
VRNS has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over VRNS on earnings quality, reporting a profit while its opponent remains loss making.
VRNS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.36 | — |
| Q3 2026 | -$1.32 | -$0.30 |
| Q2 2026 | -$1.22 | -$0.30 |
| Q1 2026 | -$1.13 | -$0.32 |
| Q4 2025 | -$1.13 | -$0.27 |
| Q3 2025 | -$1.02 | -$0.27 |
| Q2 2025 | -$0.92 | -$0.12 |
| Q1 2025 | -$0.81 | +$0.13 |
| Q4 2024 | -$0.86 | +$0.06 |
VRNS lost $1.32 per share over the past year, a bigger loss than the year before.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over VRNS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over VRNS on profitability, with a higher operating margin.
VRNS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $189.5M | +17% |
| Q2 2026 | $180M | +18% |
| Q1 2026 | $173.1M | +27% |
| Q4 2025 | $173.4M | +9.4% |
| Q3 2025 | $161.6M | +9.1% |
| Q2 2025 | $152.2M | +17% |
| Q1 2025 | $136.4M | +20% |
| Q4 2024 | $158.5M | +2.9% |
VRNS's revenue has grown year over year for 12 quarters in a row: $189M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -25% | -2.9 points |
| Q2 2026 | -23% | +1.4 points |
| Q1 2026 | -26% | +6.4 points |
| Q4 2025 | -17% | -6.4 points |
| Q3 2025 | -22% | -6.3 points |
| Q2 2025 | -24% | -1.9 points |
| Q1 2025 | -32% | +9.7 points |
| Q4 2024 | -11% | -7.7 points |
VRNS's operating margin was −25% last quarter, down 2.9 points from the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over VRNS on cash flow, with more consistent year-over-year improvement.
VRNS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26.6M | -13% |
| Q2 2026 | $20.7M | +15% |
| Q1 2026 | $50.1M | -24% |
| Q4 2025 | $20.7M | +4.1% |
| Q3 2025 | $30.4M | +43% |
| Q2 2025 | $18M | +65% |
| Q1 2025 | $65.7M | +16% |
| Q4 2024 | $19.9M | +140% |
VRNS generated $118M in free cash flow over the past year, down 12% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over VRNS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
VRNS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +180K shares |
| 1 year | 0% | +24.1K shares |
| 3 years | +5.1% | +5.6M shares |
| 5 years | +7.4% | +8M shares |
| Available history | +27% | +24.2M shares |
VRNS has 115M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $135M |
| Q4 2025 | $15M |
| Q3 2025 | — |
| Q2 2025 | $38.7M |
| Q1 2025 | $61.3M |
| Q4 2024 | — |
VRNS spent $150M buying back its own shares over the past year, up 50% from the year before.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
VRNS Net Leverage
VRNS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
VRNS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.7 | Neutral |
| Stochastic | 86.9 | Overbought |
VRNS's weekly RSI is 63 (neutral) and its Stochastic is 87 (overbought).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
VRNS PE vs Technology Sector
VRNS has no meaningful PE right now: it lost money over the past year.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
VRNS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $48.5 | 1.1% above |
| 20 week MA | $46.1 | 6.5% above |
| 50 week MA | $35.7 | 37% above |
| 100 week MA | $41.6 | 18% above |
| 200 week MA | $40.6 | 21% above |
VRNS has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.
VRNS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $26.2 | $56.7 | +117% |
| 2021 | $56.7 | $49.2 | -13% |
| 2022 | $49.2 | $23.4 | -52% |
| 2023 | $23.4 | $45.3 | +93% |
| 2024 | $45.3 | $45.0 | -0.7% |
| 2025 | $45.0 | $33.6 | -25% |
| 2026 YTD | $33.6 | $49.1 | +46% |
VRNS has the edge over NVDA on returns for 2026, with the stronger performance.